Prime Medicine (PRME) Change in Account Payables (2021 - 2026)
Prime Medicine (PRME) posted Change in Account Payables of $3.6 million for Q1 2026, up 711.36% on a QoQ basis from -$581000.0 in Q4 2025, and up 88.54% year-over-year from $1.9 million in Q1 2025.
Prime Medicine (PRME) Change in Account Payables (2021 - 2026) Analysis & Trends
Prime Medicine's Change in Account Payables history runs 6 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- Quarterly Change in Account Payables rose 88.54% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (up 6.26% YoY) and the FY2025 annual result came in at $996000.0, up 118.95% from the prior year.
- Change in Account Payables was $3.6 million for Q1 2026 at Prime Medicine, up from -$581000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $5.8 million in Q3 2023 and bottomed at -$5.9 million in Q1 2024.
- A 5-year average of $640529.4 and a median of $1.4 million in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables jumped 1535.66% — and 2024, when it sank 1066.67%.
- Prime Medicine's Change in Account Payables stood at $431000.0 in 2022, then surged by 428.77% to $2.3 million in 2023, then grew by 7.94% to $2.5 million in 2024, then tumbled by 123.62% to -$581000.0 in 2025, then surged by 711.36% to $3.6 million in 2026.
- Business Quant data shows PRME's Change in Account Payables at $3.6 million in Q1 2026, -$581000.0 in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.86 Mn |
| 10 | Prime Medicine | 524.20 Mn | 524.20 Mn | - | 3.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.55 Mn |
| Mar 31, 2026 | 3.55 Mn |
| Dec 31, 2025 | -581,000.00 |
| Dec 31, 2025 | -581,000.00 |
| Sep 30, 2025 | 3.04 Mn |
| Sep 30, 2025 | 3.04 Mn |
| Jun 30, 2025 | -3.35 Mn |
| Jun 30, 2025 | -3.35 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Mar 31, 2025 | 1.88 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Dec 31, 2024 | 2.46 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | -3.35 Mn |
| Jun 30, 2024 | -3.35 Mn |
| Mar 31, 2024 | -5.88 Mn |
| Mar 31, 2024 | -5.88 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Dec 31, 2023 | 2.28 Mn |